Insulin-like growth factor agonist molecules
US6121416A · kind A · utility
13Cited by
27References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 1997 |
| Grant date | Sep 19, 2000 |
| Priority date | — |
| Expiry date | Apr 4, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are provided that prevent the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs in a mammal
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.